Highlights on Deferasirox Use and its Renal Toxicity in Children with Beta Thalassemia Major

Iron Chelation Therapy in Beta Thalassemia

Cystatin C as an Early Marker of Glomerular Dysfunction in Children with Beta Thalassemia Major

Assessment of Iron Status in Anemic Children with Chronic Kidney Disease

SERUM CYSTATIN-C VERSUS URINARY ALBUMIN CREATININE RATIO AS AN EARLY INDICATOR OF KIDNEY DYSFUNCTION IN CHILDREN AFFECTED BY B-THALASSEMIA MAJOR

Cardiac affection in pediatric patients with β- thalassemia major.

Effect of nursing care protocol on clinical outcomes of Thalassemic children who receiving iron chelation therapy

Serum Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for Early Renal Dysfunction in Adult Egyptian Patients with b-Thalassemia Major

Serum Hepcidin and Growth Differentiation Factor 15 In Patients with β-thalassemia and Its Relation to Blood Transfusion

Study of Erythroferone Hormone in Children with Beta Thalassemia Major